EquitiesIndia.com

Healthcare · Drug Manufacturers - Specialty & Generic

Alkem Laboratories Ltd.

ALKEM

Alkem Laboratories Limited, a pharmaceutical company, engages in the research and development, manufacture, and sale of pharmaceutical and nutraceutical products in India, the United States, and internationally. The company offers branded generics, generic drugs, active pharmaceutical ingredients, and biosimilars, and nutraceuticals in acute and chronic therapeutic areas comprising anti-infective, gastroenterology, pain management, iron deficiency, diabetology, central nervous system, anti-osteoporosis, gynecology, respiratory, ophthalmology, rheumatology, urology, dermatology, cardiology, neurology, and oncology. It also provides vitamins, minerals, and nutrients; cough syrups, hepatoprotective tonic, anti-dandruff shampoo, mouth wash, pregnancy detection kits, and condoms; and anti-bloating syrups, tablets, and powder. The company was incorporated in 1973 and is headquartered in Mumbai, India.

Key metrics

Market Cap

₹65,043 cr

P/E Ratio

27.4x

P/B Ratio

5.43x

ROE

18.07%

ROCE

19.56%

Debt / Equity

0.12x

Net Margin

16.91%

Dividend Yield

94%

EPS

₹181.11

Period

FY2025

Shareholding pattern

As of Latest
Promoter: 62.91%FII: 24.92%Public: 12.17%

Deep-dive pages

Educational content — not investment adviceThis page presents publicly available information about Alkem Laboratories Ltd. for educational purposes only. EquitiesIndia.com is not a SEBI-registered Investment Adviser or Research Analyst. Nothing here constitutes investment advice, a recommendation to buy or sell any security, or a solicitation to transact. All financial data shown is sourced from public BSE/NSE filings and is at least 90 days old. Past performance is not indicative of future results. Please consult a SEBI-registered adviser before making any investment decision.